期刊文献+

多发性硬化患者病情演变与tau蛋白关系的研究 被引量:2

Relationship between tau protein and multiple sclerosis
下载PDF
导出
摘要 目的探讨神经元损伤的标志物tau蛋白与多发性硬化患者病情演变的关系。方法 48例多发性硬化患者分为复发-缓解组和继发进展组,MSSS和EDSS量表评定疾病严重程度及致残状况。ELISA法测定患者脑脊液和血清总-tau(total-tau,T-tau)蛋白和磷酸化-tau(phospho-tau,P-tau)蛋白浓度。结果复发-缓解组患者脑脊液T-tau蛋白浓度明显高于继发进展组(P=0.01)。多发性硬化患者脑脊液T-tau蛋白与EDSS评分呈负相关(γ=-0.58,P=0.0006)。结论多发性硬化患者病程中脑脊液总tau蛋白浓度的变化,间接反映脑实质损伤的程度。 Objective To investigate the relationship between tau protein and multiple sclerosis (MS). Methods Cerebrospinal fluid (CSF) and blood samples were collected from 48 patients with multiple sclerosis. Total-tau(T-tau) and phosphor tau (P-tau) concentrations were assayed with ELISA and correlated with clinical characteristics. Results T-tau concentration in CSF was significantly higher in relapsing-remitting (RR) compared to secondary progressive (SP) MS patients (P=0.01). Ttau in the CSF was negatively correlated to EDSS (γ= -0.58,P=0. 0006). Conclusion T-tau concentration in CSF of MS patients in the course of disease maybe reflect the degree of parenchymal brain loss.
出处 《中国实用神经疾病杂志》 2012年第17期15-17,共3页 Chinese Journal of Practical Nervous Diseases
关键词 多发性硬化 TAU蛋白 EDSS评分 Multiple sclerosis Tau protein EDSS
  • 相关文献

参考文献10

  • 1Compston A,Cole A. Multiple sclerosis[J]. Lancet .2002,359 : 1 221-1 231.
  • 2Terzi M, Birinci A, Cetinkaya E,et al. Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis [J]. Acta Neurol Scand5 2007,115: 325-330.
  • 3Guimaraes J, Cardoso MJ, Sa MJ. Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis[J]. Mult Scler,2006.12:354-356.
  • 4Roxburgh RH, Seaman SR,Masterman T,et al. Multiplesclerosis severity score ? using disability and disease duration to rate disease severity[J]. Neurology.2005 ,64 : 1 14-4-1 151.
  • 5Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale ( EDSS) [J] . Neurology, 1983,33:1 444-1 452.
  • 6McDonald WI,Compston A,Edan G,et al. Recommended diagnostic criteria for multiple sclerosis : guidelines from the international panel on the diagnosis of multiple sclerosis [J ] . Ann Neurol,2001,50:121-127.
  • 7Zemlan FP, Jauch EC, Mulchahey JJ,et al. C-tau biomarker of neuronal damage in severe brain injury patients: association with elevated intracranial pressure and clinical outcome [J].Brain Res, 2002,947 :131-139.
  • 8Sole-Padulles C,Llado A,Bartres-Faz D, et al. Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer’s disease continuum [J]. Psych Res,2011,192:140-146.
  • 9Stadelman C. Multiple sclerosis as neurodegenerative disease: pathology, mechanisms and therapeutic implications[J]. Curr Opin Neurol,2011,24:224-229.
  • 10Reynolds R, Roncaroli F, Nicholas R, et al. The neuropatho-logical basis of clinical progression in multiple sclerosis[J]. Acta Neuropathol, 2011,122 : 155-170.

同被引文献55

  • 1邱伟,胡学强.脑脊液寡克隆区带检测在神经系统疾病诊断中的意义——附136例报告[J].新医学,2006,37(10):638-640. 被引量:16
  • 2Raphael I, Webb J, Stuve O, et al. Body fluid biomarkers in multiple sclerosis : how far we have come and how they could affect the clinic now and in the future[ J]. Expert Rev Clin Immunol, 2015, 11: 69-91.
  • 3Katsavos S, Anagnostouli M. Biomarkers in multiple sclerosis: an up-to-date overview[J]. Mult Scler Int, 2013, 2013: 340508.
  • 4Comabella M, Montalban X. Body fluid biomarkers in multiple sclerosis[ J]. Lancet Neurol, 2014, 13 ( 1 ) : 113-126.
  • 5Lowenthal A, Vansande M, Kareher D. The differential diagnosis of neurological diseases by fractionating eleetrophoretically the CSF gamma-globulins [ J ]. J Neuroehem, 1960, 6 : 51-56.
  • 6Dobson R, Ramagopalan S, Davis A, et al. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude[ J]. J Neurol Neurosurg Psychiatry, 2013, 84 (8) : 909- 914.
  • 7Chang KH, Lyu RK, Chen CM, et al. Clinical characteristics of multiple sclerosis in Taiwan: a cross-sectional study [ J ]. Mult Seler, 2006, 12(4): 501-506.
  • 8Li B, Dong H, Zhang J, et al. Cerebrospinal fluid IgG profiles and oligoelonal bands in Chinese patients with multiple sclerosis [J]. Acta Neurol Scand, 2007, 115(5) : 319-324.
  • 9Owens GP, Bennett JL, Lassmann H, et al. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid[J]. Ann Neurol, 2009, 65(6) : 639-649.
  • 10Von Budingen HC, Gulati M, Kuenzle S, et al. Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce "oligoclonal bands" [ J]. J Neuroimmunol, 2010, 218 ( 1-2 ) : 134-139.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部